Real-world data of EGFR minor mutated NSCLC treated with EGFR-TKI: Comparative analysis including compound mutation and de novo T790M mutation

被引：0

作者：

Tanaka, K. ^{[1
]}

Inui, N. ^{[2
]}

Asada, K. ^{[3
]}

Abe, T. ^{[4
]}

Hataji, O. ^{[5
]}

Hayai, S. ^{[6
]}

Ito, K. ^{[5
]}

Imaizumi, K. ^{[7
]}

Kimura, T. ^{[8
]}

Kubo, A. ^{[9
]}

Kunii, E. ^{[10
]}

Murotani, K. ^{[11
]}

Okuno, M. ^{[12
]}

Oya, Y. ^{[13
]}

Shindoh, J. ^{[4
]}

Taniguchi, H. ^{[14
]}

Tsuda, T. ^{[14
]}

Yamaguchi, T. ^{[13
]}

Hida, T. ^{[13
]}

Suda, T. ^{[1
]}

机构：

[1] Hamamatsu Univ Sch Med, Internal Med 2, Hamamatsu, Shizuoka, Japan

[2] Hamamatsu Univ Sch Med, Dept Clin Pharmacol & Therapuet, Hamamatsu, Shizuoka, Japan

[3] Shizuoka Prefectural Gen Hosp, Dept Resp, Shizuoka, Japan

[4] Ogaki Municipal Hosp, Dept Resp Med, Ogaki, Japan

[5] Matsusaka City Hosp, Resp Ctr, Matsusaka, Japan

[6] Chutoen Gen Med Ctr, Dept Resp Med, Kakegawa, Japan

[7] Fujita Hlth Univ, Dept Resp Med, Toyoake, Aichi, Japan

[8] Tosei Gen Hosp, Dept Resp Med & Allergy, Seto, Japan

[9] Aichi Med Univ, Div Resp Med & Allergol, Nagakute, Aichi, Japan

[10] Nagoya City West Med Ctr, Dept Resp Med, Resp Tract Oncol Ctr, Nagoya, Aichi, Japan

[11] Kurume Univ, Grad Sch Med, Biostat Ctr, Kurume, Fukuoka, Japan

[12] Aichi Hosp, Aichi Canc Ctr, Dept Resp Med, Okazaki, Aichi, Japan

[13] Aichi Canc Ctr Hosp, Dept Thorac Oncol, Nagoya, Aichi, Japan

[14] Toyama Prefectural Cent Hosp, Dept Internal Med, Toyama, Japan

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

521P

引用

页数：1

共 50 条

[31] Highly Sensitive Detection of EGFR T790M Mutation in Pre-TKI Specimens of EGFR-Mutated NSCLC: In Cis, In Trans, or a Different Clone?
Leone, Alvaro
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (03) : E26 - E27
[32] T790M is associated with a favorable prognosis in Japanese patients treated with an EGFR-TKI
Uramoto, Hidetaka
Yano, Seiji
Tanaka, Fumihiro
LUNG CANCER, 2012, 76 (01) : 129 - 130
[33] Correlation between re-biopsy site and detection of T790M mutation in NSCLC patients treated with EGFR TKI
Shigematsu, Fumie
Kogure, Yoshihito
Saka, Hideo
Yamada, Arisa
Ishida, Akane
Ise, Yuko
Hori, Kazumi
Oka, Saori
Nakahata, Masashi
Kitagawa, Chiyoe
Oki, Masahide
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[34] The role of T790M mutation in EGFR-TKI re-challenge for patients with EGFR-mutant advanced lung adenocarcinoma
Zhang, Qiuyi
Ke, Ee
Niu, Feiyu
Deng, Wei
Chen, Zhihong
Xu, Chongrui
Zhang, Xuchao
Zhao, Ning
Su, Jian
Yang, Jinji
Yan, Honghong
Wu, Yilong
Zhou, Qing
ONCOTARGET, 2017, 8 (03) : 4994 - 5002
[35] RETROSPECTIVE ANALYSIS OF REBIOPSIES IN A COHORT OF EGFR-MUTATED NSCLC-PATIENTS WITH TKI-RESISTANCE; INCIDENCE OF THE T790M MUTATION.
Kuiper, Justine L.
Thunnissen, Erik
Heideman, Danielle A. M.
Paul, Marinus A.
Smit, Egbert F.
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1083 - S1084
[36] Inhibition of β-Catenin Enhances the Anticancer Effect of Irreversible EGFR-TKI in EGFR-Mutated Non-small-cell Lung Cancer with a T790M Mutation
Togashi, Yosuke
Hayashi, Hidetoshi
Terashima, Masato
de Velasco, Marco A.
Sakai, Kazuko
Fujita, Yoshihiko
Tomida, Shuta
Nakagawa, Kazuhiko
Nishio, Kazuto
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (01) : 93 - 101
[37] Prior EGFR-TKI Treatment in EGFR-Mutated NSCLC Affects the Allele Frequency Fraction of Acquired T790M and the Subsequent Efficacy of Osimertinib
Chih-Hsi Scott Kuo
Chi-Hsien Huang
Chien-Ying Liu
Stelios Pavlidis
Ho-Wen Ko
Fu-Tsai Chung
Tin-Yu Lin
Chih-Liang Wang
Yi-Ke Guo
Cheng-Ta Yang
Targeted Oncology, 2019, 14 : 433 - 440
[38] Osimertinib in EGFR T790M Advanced NSCLC: Analysis of Uncommon/Complex EGFR Mutations in a Real-World Study (ASTRIS)
Cheema, P.
Passaro, A.
Martin, C.
Tiseo, M.
Park, K.
Chang, G.
Hu, Y.
Cho, B. C.
Miranda, M.
Fernandes, A.
Freitas, H.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S854 - S854
[39] Prior EGFR-TKI Treatment in EGFR-Mutated NSCLC Affects the Allele Frequency Fraction of Acquired T790M and the Subsequent Efficacy of Osimertinib
Kuo, Chih-Hsi Scott
Huang, Chi-Hsien
Liu, Chien-Ying
Pavlidis, Stelios
Ko, Ho-Wen
Chung, Fu-Tsai
Lin, Tin-Yu
Wang, Chih-Liang
Guo, Yi-Ke
Yang, Cheng-Ta
TARGETED ONCOLOGY, 2019, 14 (04) : 433 - 440
[40] Association of EGFR Exon 19 Deletion and EGFR-TKI Treatment Duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer Patients
Matsuo, Norikazu
Azuma, Koichi
Sakai, Kazuko
Hattori, Satoshi
Kawahara, Akihiko
Ishii, Hidenobu
Tokito, Takaaki
Kinoshita, Takashi
Yamada, Kazuhiko
Nishio, Kazuto
Hoshino, Tomoaki
SCIENTIFIC REPORTS, 2016, 6

← 1 2 3 4 5 →